NewEdge Advisors’s Verona Pharma VRNA Stock Holding History

NewEdge Advisors’s Portfolio VRNA Stock Details VRNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-962	Closed	-$103K	–	4385
2025 Q3	$103K	Buy	962 +50	+5%	+$5.22K	﹤0.01%	2599
2025 Q2	$86.3K	Hold	912	–	–	﹤0.01%	2469
2025 Q1	$57.9K	Buy	+912	New	+$54.6K	﹤0.01%	2502
2024 Q3	–	Sell	-7,300	Closed	-$106K	–	3949
2024 Q2	$106K	Buy	+7,300	New	+$107K	﹤0.01%	2096

Other funds holding VRNA

DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return

NewEdge Advisors's VRNA Position: Q4 2025 in Review

NewEdge Advisors sold out of Verona Pharma (VRNA) in Q4 2025, closing a stake of 962 shares — an estimated $103K sold.

NewEdge Advisors first reported a position in VRNA in Q2 2024 and held it in 4 quarters. The position peaked at $106K in Q2 2024. 1 fund tracked by Wall St. Rank holds VRNA as of Q4 2025.

NewEdge Advisors reported no remaining Verona Pharma position as of Q4 2025 after selling out during the quarter.
NewEdge Advisors sold 962 Verona Pharma shares in Q4 2025, an estimated $103K.
NewEdge Advisors first reported a position in Verona Pharma in Q2 2024 and held it in 4 quarters.
NewEdge Advisors's Verona Pharma position peaked at $106K in Q2 2024.
1 fund tracked by Wall St. Rank held Verona Pharma as of Q4 2025.

Based on NewEdge Advisors's 13F filing for Q4 2025, filed 18 Feb 2026.